- Home
- RMM vs ANIK Comparison
RMM vs ANIK Comparison
Compare RMM & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMM | ANIK |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.0M | 142.5M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | RMM | ANIK |
|---|---|---|
| Price | $13.91 | $9.57 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 66.5K | ★ 182.3K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 7.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | N/A | ★ $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | $15.55 | ★ N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $12.32 | $7.87 |
| 52 Week High | $16.10 | $18.37 |
Technical Indicators
Market Signals| Indicator | RMM | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 47.89 |
| Support Level | $13.80 | $9.48 |
| Resistance Level | $14.05 | $9.75 |
| Average True Range (ATR) | 0.13 | 0.26 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 59.41 | 24.05 |
Price Performance
Historical ComparisonAbout RMM RiverNorth Managed Duration Municipal Income Fund Inc.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.